These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1876819)

  • 41. Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease.
    Schneider LS; Farlow M
    Ann N Y Acad Sci; 1997 Sep; 826():317-22. PubMed ID: 9329702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neuroprotective therapy of Alzheimer's disease?].
    Mielke R
    Dtsch Med Wochenschr; 1996 Nov; 121(48):1515. PubMed ID: 8983909
    [No Abstract]   [Full Text] [Related]  

  • 43. Tacrine, and Alzheimer's treatments.
    Summers WK
    J Alzheimers Dis; 2006; 9(3 Suppl):439-45. PubMed ID: 16914883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A
    Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract]   [Full Text] [Related]  

  • 45. Alternatives in the treatment of memory loss in patients with Alzheimer's disease.
    Volger BW
    Clin Pharm; 1991 Jun; 10(6):447-56. PubMed ID: 2065522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tacrine therapy for the dementia of Alzheimer's disease.
    Manning FC
    Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alzheimer's disease: the tacrine legacy.
    Kelly JS
    Trends Pharmacol Sci; 1999 Apr; 20(4):127-9. PubMed ID: 10348719
    [No Abstract]   [Full Text] [Related]  

  • 48. Tacrine in Alzheimer's disease.
    Levy R
    Lancet; 1989 Aug; 2(8658):329. PubMed ID: 2569126
    [No Abstract]   [Full Text] [Related]  

  • 49. Alzheimer's disease.
    Hier DB
    Surg Neurol; 1997 Jan; 47(1):84-5. PubMed ID: 8986173
    [No Abstract]   [Full Text] [Related]  

  • 50. No association between tacrine transaminitis and the glutathione transferase theta genotype in patients with Alzheimer's disease.
    De Sousa M; Pirmohamed M; Kitteringham NR; Woolf T; Park BK
    Pharmacogenetics; 1998 Aug; 8(4):353-5. PubMed ID: 9731722
    [No Abstract]   [Full Text] [Related]  

  • 51. Alzheimer's disease and caregiver time.
    Moore MJ; Clipp EC
    Lancet; 1994 Jan; 343(8891):239-40. PubMed ID: 7904698
    [No Abstract]   [Full Text] [Related]  

  • 52. (+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.
    Shutske GM; Pierrat FA; Cornfeldt ML; Szewczak MR; Huger FP; Bores GM; Haroutunian V; Davis KL
    J Med Chem; 1988 Jul; 31(7):1278-9. PubMed ID: 3385720
    [No Abstract]   [Full Text] [Related]  

  • 53. Development of memory-enhancing agents in the treatment of Alzheimer's disease.
    Abernethy DR
    J Am Geriatr Soc; 1987 Oct; 35(10):957-8. PubMed ID: 2888798
    [No Abstract]   [Full Text] [Related]  

  • 54. Meta-analysis of tacrine for Alzheimer disease: the influence of industry sponsors.
    Koepp R; Miles SH
    JAMA; 1999 Jun 23-30; 281(24):2287-8. PubMed ID: 10386551
    [No Abstract]   [Full Text] [Related]  

  • 55. [New therapeutic prospects in Alzheimer disease].
    Rouhart F
    Rev Med Interne; 1995; 16(11):860-3. PubMed ID: 8570945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Alzheimer's disease].
    Derouesné C
    Presse Med; 1992 Jan 4-11; 21(1):13-5. PubMed ID: 1531257
    [No Abstract]   [Full Text] [Related]  

  • 57. Putative mechanisms of action of tacrine in Alzheimer's disease.
    Adem A
    Acta Neurol Scand Suppl; 1992; 139():69-74. PubMed ID: 1384265
    [No Abstract]   [Full Text] [Related]  

  • 58. Key molecular pathways leading to Alzheimer's identified. Research approach highlights potential therapeutic targets.
    Am J Alzheimers Dis Other Demen; 2013 Sep; 28(6):643-4. PubMed ID: 24137742
    [No Abstract]   [Full Text] [Related]  

  • 59. [Trends in mechanism-based studies on the treatment of Alzheimer's disease].
    Saido T
    Nihon Ronen Igakkai Zasshi; 2007 Nov; 44(6):690-3. PubMed ID: 18200756
    [No Abstract]   [Full Text] [Related]  

  • 60. [Neuropeptides and neurological diseases: Alzheimer's disease].
    Nakamura S
    Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1709-12. PubMed ID: 2625589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.